We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ERNA

Price
2.83
Stock movement down
-0.18 (-6.84%)
Company name
Eterna Therapeutics Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
8.39M
Ent value
57.24M
Price/Sales
14.03
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-0.09%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-91.71%
3 year return
-75.28%
5 year return
-68.17%
10 year return
-56.54%
Last updated: 2025-06-22

iO Charts is a Seeking Alpha partner

DIVIDENDS

ERNA does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales14.03
Price to Book-
EV to Sales95.72

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count3.42M
EPS (TTM)-124.58
FCF per share (TTM)-48.08

Income statement

Loading...
Income statement data
Revenue (TTM)598.00K
Gross profit (TTM)-586.00K
Operating income (TTM)-18.74M
Net income (TTM)-44.93M
EPS (TTM)-124.58
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-97.99%
Operating margin (TTM)-3134.11%
Profit margin (TTM)-7513.88%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash4.26M
Net receivables187.00K
Total current assets4.73M
Goodwill2.04M
Intangible assets0.00
Property, plant and equipment824.00K
Total assets7.72M
Accounts payable2.19M
Short/Current long term debt33.55M
Total current liabilities9.95M
Total liabilities53.11M
Shareholder's equity-45.39M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-16.95M
Capital expenditures (TTM)388.00K
Free cash flow (TTM)-17.34M
Dividends paid (TTM)16.00K

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-582.18%
Return on Invested Capital341.57%
Cash Return on Invested Capital131.81%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open2.64
Daily high2.64
Daily low2.45
Daily Volume38K
All-time high333750.00
1y analyst estimate45.00
Beta7.77
EPS (TTM)-124.58
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ERNAS&P500
Current price drop from All-time high-100.00%-2.16%
Highest price drop-100.00%-56.47%
Date of highest drop9 Jun 20259 Mar 2009
Avg drop from high-84.07%-11.04%
Avg time to new high303 days12 days
Max time to new high8006 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ERNA (Eterna Therapeutics Inc) company logo
Marketcap
8.39M
Marketcap category
Small-cap
Description
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Employees
8
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...